- Home
- FLUX vs PASG Comparison
FLUX vs PASG Comparison
Compare FLUX & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLUX | PASG |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 28.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | FLUX | PASG |
|---|---|---|
| Price | $1.31 | $8.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $8.00 | ★ $34.50 |
| AVG Volume (30 Days) | ★ 139.0K | 57.7K |
| Earning Date | 02-12-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $63,484,000.00 | N/A |
| Revenue This Year | $0.18 | N/A |
| Revenue Next Year | $29.72 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.13 | N/A |
| 52 Week Low | $1.06 | $5.12 |
| 52 Week High | $7.55 | $20.00 |
Technical Indicators
Market Signals| Indicator | FLUX | PASG |
|---|---|---|
| Relative Strength Index (RSI) | 46.07 | 36.30 |
| Support Level | $1.06 | $8.86 |
| Resistance Level | $1.47 | $10.63 |
| Average True Range (ATR) | 0.12 | 1.38 |
| MACD | 0.00 | -0.45 |
| Stochastic Oscillator | 55.10 | 2.71 |
Price Performance
Historical ComparisonAbout FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.